Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 520

1.

How does homeostasis happen? Integrative physiologic, systems biologic, and evolutionary perspectives.

Goldstein DS.

Am J Physiol Regul Integr Comp Physiol. 2019 Jan 16. doi: 10.1152/ajpregu.00396.2018. [Epub ahead of print]

PMID:
30649893
2.

Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension.

Lamotte G, Holmes C, Sullivan P, Goldstein DS.

Clin Auton Res. 2019 Feb;29(1):113-117. doi: 10.1007/s10286-018-0564-5. Epub 2018 Sep 18.

PMID:
30229336
3.

Cerebrospinal Fluid-Directed rAAV9-rsATP7A Plus Subcutaneous Copper Histidinate Advance Survival and Outcomes in a Menkes Disease Mouse Model.

Haddad MR, Choi EY, Zerfas PM, Yi L, Martinelli D, Sullivan P, Goldstein DS, Centeno JA, Brinster LR, Ralle M, Kaler SG.

Mol Ther Methods Clin Dev. 2018 Jul 9;10:165-178. doi: 10.1016/j.omtm.2018.07.002. eCollection 2018 Sep 21.

4.

Roles of cardiac sympathetic neuroimaging in autonomic medicine.

Goldstein DS, Cheshire WP Jr.

Clin Auton Res. 2018 Aug;28(4):397-410. doi: 10.1007/s10286-018-0547-6. Epub 2018 Jul 30. Review.

PMID:
30062642
5.

Roles of catechol neurochemistry in autonomic function testing.

Goldstein DS, Cheshire WP.

Clin Auton Res. 2018 Jun;28(3):273-288. doi: 10.1007/s10286-018-0528-9. Epub 2018 Apr 28. Review.

PMID:
29705971
6.

3,4-Dihydroxyphenylacetaldehyde-Induced Protein Modifications and Their Mitigation by N-Acetylcysteine.

Jinsmaa Y, Sharabi Y, Sullivan P, Isonaka R, Goldstein DS.

J Pharmacol Exp Ther. 2018 Jul;366(1):113-124. doi: 10.1124/jpet.118.248492. Epub 2018 Apr 26.

7.

Cerebrospinal fluid biomarkers of central dopamine deficiency predict Parkinson's disease.

Goldstein DS, Holmes C, Lopez GJ, Wu T, Sharabi Y.

Parkinsonism Relat Disord. 2018 May;50:108-112. doi: 10.1016/j.parkreldis.2018.02.023. Epub 2018 Feb 15.

PMID:
29475591
8.

Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies.

Norcliffe-Kaufmann L, Kaufmann H, Palma JA, Shibao CA, Biaggioni I, Peltier AC, Singer W, Low PA, Goldstein DS, Gibbons CH, Freeman R, Robertson D; Autonomic Disorders Consortium.

Ann Neurol. 2018 Mar;83(3):522-531. doi: 10.1002/ana.25170. Epub 2018 Mar 10.

PMID:
29405350
9.

Spectrum of abnormalities of sympathetic tyrosine hydroxylase and alpha-synuclein in chronic autonomic failure.

Isonaka R, Sullivan P, Jinsmaa Y, Corrales A, Goldstein DS.

Clin Auton Res. 2018 Apr;28(2):223-230. doi: 10.1007/s10286-017-0495-6. Epub 2018 Feb 2.

PMID:
29396794
10.

The physical examination as a window into autonomic disorders.

Cheshire WP Jr, Goldstein DS.

Clin Auton Res. 2018 Feb;28(1):23-33. doi: 10.1007/s10286-017-0494-7. Epub 2018 Jan 2. Review.

PMID:
29294184
11.

Pleiotropic neuropathological and biochemical alterations associated with Myo5a mutation in a rat Model.

Landrock KK, Sullivan P, Martini-Stoica H, Goldstein DS, Graham BH, Yamamoto S, Bellen HJ, Gibbs RA, Chen R, D'Amelio M, Stoica G.

Brain Res. 2018 Jan 15;1679:155-170. doi: 10.1016/j.brainres.2017.11.029. Epub 2017 Dec 5.

PMID:
29217155
12.

Irwin J Kopin.

Goldstein DS, Sibley DR.

Neuropsychopharmacology. 2017 Dec;42(13):2656. doi: 10.1038/npp.2017.208. No abstract available.

13.

Beat-to-beat blood pressure and heart rate responses to the Valsalva maneuver.

Goldstein DS, Cheshire WP Jr.

Clin Auton Res. 2017 Dec;27(6):361-367. doi: 10.1007/s10286-017-0474-y. Epub 2017 Oct 19. Review.

PMID:
29052077
14.

Cardiac sympathetic denervation predicts PD in at-risk individuals.

Goldstein DS, Holmes C, Lopez GJ, Wu T, Sharabi Y.

Parkinsonism Relat Disord. 2018 Jul;52:90-93. doi: 10.1016/j.parkreldis.2017.10.003. Epub 2017 Oct 5.

PMID:
29032895
15.

The heart of PD: Lewy body diseases as neurocardiologic disorders.

Goldstein DS, Sharabi Y.

Brain Res. 2019 Jan 1;1702:74-84. doi: 10.1016/j.brainres.2017.09.033. Epub 2017 Oct 10.

PMID:
29030055
16.

Homeostatic systems, biocybernetics, and autonomic neuroscience.

Goldstein DS, Kopin IJ.

Auton Neurosci. 2017 Dec;208:15-28. doi: 10.1016/j.autneu.2017.09.001. Epub 2017 Sep 5. Review.

17.

Plasma Catechols After Eating Olives.

Goldstein DS, Holmes C, Cherup J, Sharabi Y.

Clin Transl Sci. 2018 Jan;11(1):32-37. doi: 10.1111/cts.12489. Epub 2017 Sep 12.

18.

N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.

Goldstein DS, Jinsmaa Y, Sullivan P, Sharabi Y.

Neurochem Res. 2017 Nov;42(11):3289-3295. doi: 10.1007/s11064-017-2371-0. Epub 2017 Aug 24.

PMID:
28840582
19.

The autonomic medical history.

Goldstein DS, Cheshire WP Jr.

Clin Auton Res. 2017 Aug;27(4):223-233. doi: 10.1007/s10286-017-0425-7. Epub 2017 May 27. Review.

PMID:
28551871
20.

Linking Stress, Catecholamine Autotoxicity, and Allostatic Load with Neurodegenerative Diseases: A Focused Review in Memory of Richard Kvetnansky.

Goldstein DS, Kopin IJ.

Cell Mol Neurobiol. 2018 Jan;38(1):13-24. doi: 10.1007/s10571-017-0497-x. Epub 2017 May 9. Review.

21.

Corrigendum to "Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy" [Parkinsonism Relat. Disord. 35 (2017) 88-91].

Goldstein DS, Sullivan P, Holmes C, Mash DC, Kopin IJ, Sharabi Y.

Parkinsonism Relat Disord. 2017 Jun;39:95. doi: 10.1016/j.parkreldis.2017.03.018. Epub 2017 Apr 6. No abstract available.

PMID:
28392299
22.

Autonomic function tests: introduction to the series.

Goldstein DS, Cheshire WP Jr.

Clin Auton Res. 2017 Jun;27(3):141-143. doi: 10.1007/s10286-017-0415-9. Epub 2017 Mar 17. No abstract available.

PMID:
28315024
23.

Is pure autonomic failure a distinct nosologic entity?

Isonaka R, Holmes C, Cook GA Jr, Sullivan P, Sharabi Y, Goldstein DS.

Clin Auton Res. 2017 Apr;27(2):121-122. doi: 10.1007/s10286-017-0412-z. Epub 2017 Mar 16. No abstract available.

PMID:
28303413
24.

Pure autonomic failure without synucleinopathy.

Isonaka R, Holmes C, Cook GA, Sullivan P, Sharabi Y, Goldstein DS.

Clin Auton Res. 2017 Apr;27(2):97-101. doi: 10.1007/s10286-017-0404-z. Epub 2017 Feb 10.

PMID:
28188385
25.

Obituary.

Goldstein DS.

Stress. 2017 Jan;20(1):1. doi: 10.1080/10253890.2017.1283090. Epub 2017 Feb 2. No abstract available.

PMID:
28152657
26.

Natural history of pure autonomic failure: A United States prospective cohort.

Kaufmann H, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, Low PA, Singer W, Goldstein DS, Peltier AC, Shibao CA, Gibbons CH, Freeman R, Robertson D; Autonomic Disorders Consortium.

Ann Neurol. 2017 Feb;81(2):287-297. doi: 10.1002/ana.24877.

27.

Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy.

Goldstein DS, Sullivan P, Holmes C, Mash DC, Kopin IJ, Sharabi Y.

Parkinsonism Relat Disord. 2017 Feb;35:88-91. doi: 10.1016/j.parkreldis.2016.12.011. Epub 2016 Dec 15. Erratum in: Parkinsonism Relat Disord. 2017 Jun;39:95.

28.

Autoimmunity-associated autonomic failure with sympathetic denervation.

Goldstein DS, Holmes C, Sullivan P, Donadio V, Isonaka R, Zhong E, Pourier B, Vernino S, Kopin IJ, Sharabi Y.

Clin Auton Res. 2017 Feb;27(1):57-62. doi: 10.1007/s10286-016-0388-0. Epub 2016 Nov 12.

PMID:
27838780
29.

Cardiac Dysautonomia and Survival in Hereditary Transthyretin Amyloidosis.

Goldstein DS.

JACC Cardiovasc Imaging. 2016 Dec;9(12):1442-1445. doi: 10.1016/j.jcmg.2016.08.003. Epub 2016 Nov 9. No abstract available.

30.

Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.

Goldstein DS, Holmes C, Sullivan P, Jinsmaa Y, Kopin IJ, Sharabi Y.

Parkinsonism Relat Disord. 2016 Oct;31:79-86. doi: 10.1016/j.parkreldis.2016.07.009. Epub 2016 Jul 20.

31.

A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.

Aflaki E, Borger DK, Moaven N, Stubblefield BK, Rogers SA, Patnaik S, Schoenen FJ, Westbroek W, Zheng W, Sullivan P, Fujiwara H, Sidhu R, Khaliq ZM, Lopez GJ, Goldstein DS, Ory DS, Marugan J, Sidransky E.

J Neurosci. 2016 Jul 13;36(28):7441-52. doi: 10.1523/JNEUROSCI.0636-16.2016.

32.

3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.

Goldstein DS, Jinsmaa Y, Sullivan P, Holmes C, Kopin IJ, Sharabi Y.

Neurochem Res. 2016 Sep;41(9):2173-8. doi: 10.1007/s11064-016-1959-0. Epub 2016 May 25.

33.

Systemic hemodynamics during orthostasis in multiple system atrophy.

Goldstein DS, Sims-O'Neil C.

Parkinsonism Relat Disord. 2016 Apr;25:106-7. doi: 10.1016/j.parkreldis.2016.02.009. Epub 2016 Feb 10. No abstract available.

34.

Erratum to: Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo.

Pasqua T, Mahata S, Bandyopadhyay GK, Biswas A, Perkins GA, Sinha-Hikim AP, Goldstein DS, Eiden LE, Mahata SK.

Cell Tissue Res. 2016 Mar;363(3):823. doi: 10.1007/s00441-016-2362-5. No abstract available.

35.

DOPAL is transmissible to and oligomerizes alpha-synuclein in human glial cells.

Jinsmaa Y, Sullivan P, Sharabi Y, Goldstein DS.

Auton Neurosci. 2016 Jan;194:46-51. doi: 10.1016/j.autneu.2015.12.008. Epub 2015 Dec 31.

36.

Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.

Goldstein DS, Jinsmaa Y, Sullivan P, Holmes C, Kopin IJ, Sharabi Y.

J Pharmacol Exp Ther. 2016 Feb;356(2):483-92. doi: 10.1124/jpet.115.230201. Epub 2015 Nov 16.

37.

Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo.

Pasqua T, Mahata S, Bandyopadhyay GK, Biswas A, Perkins GA, Sinha-Hikim AP, Goldstein DS, Eiden LE, Mahata SK.

Cell Tissue Res. 2016 Mar;363(3):693-712. doi: 10.1007/s00441-015-2316-3. Epub 2015 Nov 16. Erratum in: Cell Tissue Res. 2016 Mar;363(3):823.

38.

Survival in synucleinopathies: A prospective cohort study.

Goldstein DS, Holmes C, Sharabi Y, Wu T.

Neurology. 2015 Nov 3;85(18):1554-61. doi: 10.1212/WNL.0000000000002086. Epub 2015 Oct 2.

39.

Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration.

Goldstein DS, Holmes C, Sullivan P, Mash DC, Sidransky E, Stefani A, Kopin IJ, Sharabi Y.

Parkinsonism Relat Disord. 2015 Sep;21(9):1013-22. doi: 10.1016/j.parkreldis.2015.07.009. Epub 2015 Jul 17.

40.

Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.

Goldstein DS, Sullivan P, Holmes C, Kopin IJ, Sharabi Y, Mash DC.

Parkinsonism Relat Disord. 2015 Jun;21(6):567-72. doi: 10.1016/j.parkreldis.2015.03.006. Epub 2015 Mar 20.

41.

Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.

Goldstein DS, Sullivan P, Cooney A, Jinsmaa Y, Kopin IJ, Sharabi Y.

J Neurochem. 2015 Apr;133(1):14-25. doi: 10.1111/jnc.13042. Epub 2015 Feb 25.

42.

Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy.

Goldstein DS, Kopin IJ, Sharabi Y, Holmes C.

Clin Auton Res. 2015 Feb;25(1):61-7. doi: 10.1007/s10286-015-0268-z. Epub 2015 Feb 1.

43.

Tandem Duplication of Exons 1-7 Neither Impairs ATP7A Expression Nor Causes a Menkes Disease Phenotype.

Choi EY, Patel K, Haddad MR, Yi L, Holmes C, Goldstein DS, Dutra A, Pak E, Kaler SG.

JIMD Rep. 2015;20:57-63. doi: 10.1007/8904_2014_391. Epub 2015 Feb 1.

44.

The serotonin aldehyde, 5-HIAL, oligomerizes alpha-synuclein.

Jinsmaa Y, Cooney A, Sullivan P, Sharabi Y, Goldstein DS.

Neurosci Lett. 2015 Mar 17;590:134-7. doi: 10.1016/j.neulet.2015.01.064. Epub 2015 Jan 28.

45.

Predominant Glandular Cholinergic Dysautonomia in Patients With Primary Sjögren's Syndrome.

Imrich R, Alevizos I, Bebris L, Goldstein DS, Holmes CS, Illei GG, Nikolov NP.

Arthritis Rheumatol. 2015 May;67(5):1345-52. doi: 10.1002/art.39044.

46.

Sympathoneural and adrenomedullary responses to mental stress.

Carter JR, Goldstein DS.

Compr Physiol. 2015 Jan;5(1):119-46. doi: 10.1002/cphy.c140030. Review.

47.

Molecular and biochemical characterization of Mottled-dappled, an embryonic lethal Menkes disease mouse model.

Haddad MR, Patel KD, Sullivan PH, Goldstein DS, Murphy KM, Centeno JA, Kaler SG.

Mol Genet Metab. 2014 Dec;113(4):294-300. doi: 10.1016/j.ymgme.2014.10.001. Epub 2014 Oct 13.

48.

Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson's disease.

Casida JE, Ford B, Jinsmaa Y, Sullivan P, Cooney A, Goldstein DS.

Chem Res Toxicol. 2014 Aug 18;27(8):1359-61. doi: 10.1021/tx5002223. Epub 2014 Jul 24.

49.

Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo.

Lohr KM, Bernstein AI, Stout KA, Dunn AR, Lazo CR, Alter SP, Wang M, Li Y, Fan X, Hess EJ, Yi H, Vecchio LM, Goldstein DS, Guillot TS, Salahpour A, Miller GW.

Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9977-82. doi: 10.1073/pnas.1402134111. Epub 2014 Jun 16.

50.

Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders.

Goldstein DS, Kopin IJ, Sharabi Y.

Pharmacol Ther. 2014 Dec;144(3):268-82. doi: 10.1016/j.pharmthera.2014.06.006. Epub 2014 Jun 16. Review.

Supplemental Content

Loading ...
Support Center